Early neural and vascular dysfunctions in diabetic rats are largely sequelae of increased sorbitol oxidation

Antioxidants and Redox Signaling

Volumn 12, Issue 1, 2010, Pages 39-51

  Ido, Yasuo ^a   Nyengaard, Jens R ^b   Chang, Kathy ^c   Tilton, Ronald G ^d   Kilo, Charles ^c   Mylari, Banavara L ^e   Oates, Peter J ^e   Williamson, Joseph R ^c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AARHUS UNIVERSITY   (Denmark)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE; INOSITOL; LACTATE DEHYDROGENASE; LACTIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SORBITOL; SUPEROXIDE;

ALCOHOL OXIDATION; ALCOHOL PRODUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DIABETES MELLITUS; ENZYME SYNTHESIS; GLYCOLYSIS; HYPERGLYCEMIA; MALE; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; MOTOR NERVE CONDUCTION; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA NERVE CELL; SCIATIC NERVE; VASCULAR DISEASE;

ANIMALS; BLOOD VESSELS; DIABETES MELLITUS, EXPERIMENTAL; MALE; NAD; NERVOUS SYSTEM; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; SORBITOL;

RATTUS;

EID: 71549149395     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2502     Document Type: Article

References (58)

1. Ananthakrishnan R, Kaneko M, Hwang YC, Quadri N, Gomez T, Li Q, Caspersen C, and Ramasamy R. Aldose re-ductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore. Am J Physiol Heart Circ Physiol 296: H333-H341, 2009.
2. Bassenge E, Sommer O, Schwemmer M, and Bunger R. Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state. Am J Physiol Heart Circ Physiol 279: H2431-H2438, 2000.
3. Bergmeyer H. Methods of enzymatic analysis. New York: Academic Press, 1974, pp. 1836-1839.
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
5. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615-1625, 2005.
6. Cameron NE, Cotter MA, Basso M, and Hohman TC. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 40: 271-281, 1997.
7. Cameron NE, Cotter MA, and Low PA. Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 261: E1-E8, 1991.
8. Ceriello A and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24: 816-823, 2004.
9. Chang K, Allison W, Harlow J, and Willamson JR. Amino-guanidine prevents glucose-and sorbitol-induced vascular dysfunction in skin chamber granulation tissue. Diabetes 40(suppl 1): 210A, 1991.
10. Chang K, Ido Y, LeJeune W, Williamson JR, and Tilton RG. Increased sciatic nerve blood flow in diabetic rats: assessment by "molecular" vs. particulate microspheres. Am J Physiol 273: E164-E173, 1997.
11. Diederen RM, Starnes CA, Berkowitz BA, and Winkler BS. Reexamining the hyperglycemic pseudohypoxia hypothesis of diabetic oculopathy. Invest Ophthalmol Vis Sci 47: 2726-2731, 2006.
12. Frangos M, Smith S, Stantiago J, and Kilo C. Sorbitol-induced imbalances in glycolysis in human erythrocytes are reduced by pyruvate. Diabetes 39(suppl 1): S270A, 1990.
13. Geisen K, Utz R, Grotsch H, Lang HJ, and Nimmesgern H. Sorbitol-accumulating pyrimidine derivatives. Arzneimittel-forschung 44: 1032-1043, 1994.
14. Graymore CN and Brown H. The effects of sodium salicylate on the metabolism of the retina. Exp Eye Res 4: 364-369, 1965.
15. Halestrap AP, Clarke SJ, and Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Bio-chim Biophys Acta 1767: 1007-1031, 2007.
16. Hasan KS, Santiago JV, and Willamson JR. Acute hypergly-cemia-induced increases in regional blood flow are prevented by pyruvate and by tolrestat. Diabetes 42(suppl 1): 189A, 1993.
17. Heath H, Kang SS, and Philippou D. Glucose, glucose-6-phosphate, lactate and pyruvate content of the retina, blood and liver of streptozotocin-diabetic rats fed sucrose, or starch-rich diets. Diabetologia 11: 57-62, 1975.
18. Heath H, Rutter AC, and Beck TC. Reduced and oxidized pyridine nucleotides in the retinae from alloxan-diabetic rats. Vision Res 2: 333-342, 1962.
19. Hedeskov CJ, Capito K, and Thams P. Cytosolic ratios of free [NADPH]=[NADP+] and [NADH]=[NAD+] in mouse pancreatic islets, and nutrient-induced insulin secretion. Biochem J 241: 161-167, 1987.
20. Ido Y. Pyridine nucleotide redox abnormalities in diabetes. Antioxid Redox Signal 9: 931-942, 2007.
21. Ido Y, Chang K, LeJeune W, Tilton RG, Monafo WW, and Williamson JR. Diabetes impairs sciatic nerve hyperemia induced by surgical trauma: implications for diabetic neuropathy. Am J Physiol 273: E174-E184, 1997.
22. Ido Y, Chang K, and Williamson JR. NADH augments blood flow in physiologically activated retina and visual cortex. Proc Natl Acad Sci U S A 101: 653-658, 2004.
23. Ido Y, Chang K, Woolsey TA, and Williamson JR. NADH: sensor of blood flow need in brain, muscle, and other tissues. FASEB J 15: 1419-1421, 2001.
24. Kashiwagi A, Nishio Y, Asahina T, Ikebuchi M, Harada N, Tanaka Y, Takahara N, Taki H, Obata T, Hidaka H, Saeki Y, and Kikkawa R. Pyruvate improves deleterious effects of high glucose on activation of pentose phosphate pathway and glutathione redox cycle in endothelial cells. Diabetes 46: 2088-2095, 1997.
25. Kerr PM, Suleiman MS, and Halestrap AP. Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate. Am J Physiol 276: H496-H502, 1999.
26. Leto G, Pricci F, Amadio L, Iacobini C, Cordone S, Diaz-Horta O, Romeo G, Barsotti P, Rotella CM, di Mario U, and Pugliese G. Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu: role of advanced non-enzymatic glycation and polyol pathway activation. Diabetes Metab Res Rev 17: 448-458, 2001.
27. Mintun MA, Vlassenko AG, Rundle MM, and Raichle ME. Increased lactate=pyruvate ratio augments blood flow in physiologically activated human brain. Proc Natl Acad Sci U S A 101: 659-664, 2004.
28. Mylari BL, Larson ER, Beyer TA, Zembrowski WJ, Aldinger CE, Dee MF, Siegel TW, and Singleton DH. Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1- phthalazineacetic acid (zopolrestat) and congeners. J Med Chem 34: 108-122, 1991.
29. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hypergly-caemic damage. Nature 404: 787-790, 2000.
30. Nyengaard JR, Ido Y, Kilo C, and Williamson JR. Interactions between hyperglycemia and hypoxia: implications for diabetic retinopathy. Diabetes 53: 2931-2938, 2004.
31. Oates PJ. Polyol pathway and diabetic peripheral neuropathy. Int Rev Neurobiol 50: 325-392, 2002.
32. Oates PJ. Aldose reductase, still a compelling target for diabetic neuropathy. Curr Drug Targets 9: 14-36, 2008.
33. Oates PJ, Schelhorn T, Miller M, Hammerlund E, Ellery C, Beebe D, Hakkinen J. Polyol pathway inhibitors dose-dependently preserve nerve function in diabetic rats. Dia-betologia 41: A271, 1998.
34. Obrosova IG, Fathallah L, Lang HJ, and Greene DA. Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study. Diabetolo-gia 42: 1187-1194, 1999.
35. Obrosova IG, Marvel J, Faller AM, and Willamson JR. Reductive stress is a very early metabolic imbalance in sciatic nerve in diabetic and galactose-fed rats Diabetes 38(suppl 1): A8, 1995.
36. Obrosova IG, Stevens MJ, and Lang HJ. Diabetes-induced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy. Pharmacology 62: 172-180, 2001.
37. Obrosova IG, Van HuysenC,Fathallah L,Cao XC, Greene DA, Stevens MJ. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J 16: 123-125, 2002.
38. Peterson MJ, Sarges R, Aldinger CE, and MacDonald DP. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats. Metabolism 28: 456-461, 1979.
39. Pugliese G, Tilton RG, Speedy A, Chang K, Province MA, Kilo C, and Williamson JR. Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity. Metabolism 39: 690-697, 1990.
40. Pugliese G, Tilton RG, Speedy A, Santarelli E, Eades DM, Province MA, Kilo C, Sherman WR, and Williamson JR. Modulation of hemodynamic and vascular filtration changes in diabetic rats by dietary myo-inositol. Diabetes 39: 312-322, 1990. (Pubitemid 20076214)
41. Salceda R, Vilchis C, Coffe V, and Hernandez-Munoz R. Changes in the redox state in the retina and brain during the onset of diabetes in rats. Neurochem Res 23: 893-897, 1998.
42. Salway JG. Metabolism at a glance. Cambridge, MA: Blackwell Science, 1994, pp. 34-35.
43. Scholz TD, Laughlin MR, Balaban RS, Kupriyanov VV, and Heineman FW. Effect of substrate on mitochondrial NADH, cytosolic redox state, and phosphorylated compounds in isolated hearts. Am J Physiol 268: H82-H91, 1995.
44. Tilton RG, Baier LD, Harlow JE, Smith SR, Ostrow E, and Williamson JR. Diabetes-induced glomerular dysfunction: links to a more reduced cytosolic ratio of NADH=NAD+. Kidney Int 41: 778-788, 1992.
45. Tilton RG, Chang K, Nyengaard JR, Van den Enden M, Ido Y, and Williamson JR. Inhibition of sorbitol dehydrogenase: effects on vascular and neural dysfunction in streptozocin-induced diabetic rats. Diabetes 44: 234-242, 1995.
46. Tilton RG, Kawamura T, Chang KC, Ido Y, Bjercke RJ, Stephan CC, Brock TA, and Williamson JR. Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J Clin Invest 99: 2192-2202, 1997.
47. Toth E, Racz A, Toth J, Kaminski PM, Wolin MS, Bagi Z, and Koller A. Contribution of polyol pathway to arteriolar dysfunction in hyperglycemia: role of oxidative stress, reduced NO, and enhanced PGH(2)=TXA(2) mediation. Am J Physiol Heart Circ Physiol 293: H3096-H3104, 2007.
48. Travis SF, Morrison AD, Clements RS Jr, Winegrad AI, and Oski FA. Metabolic alterations in the human erythrocyte produced by increases in glucose concentration: the role of the polyol pathway. J Clin Invest 50: 2104-2112, 1971.
49. Turner JL and Bierman EL. Effects of glucose and sorbitol on proliferation of cultured human skin fibroblasts and arterial smooth-muscle cells. Diabetes 27: 583-588, 1978.
50. Van den Enden MK, Nyengaard JR, Ostrow E, Burgan JH, and Williamson JR. Elevated glucose levels increase retinal glycol-ysis and sorbitol pathway metabolism: implications for diabetic retinopathy. Invest Ophthalmol Vis Sci 36: 1675-1685, 1995.
51. Vlassenko AG, Rundle MM, Raichle ME, and Mintun MA. Regulation of blood flow in activated human brain by cy-tosolic NADH=NAD+ ratio. Proc Natl Acad Sci U S A 103: 1964-1969, 2006.
52. Whiteside CI. Cellular mechanisms and treatment of diabetes vascular complications converge on reactive oxygen species. Curr Hypertens Rep 7: 148-154, 2005.
53. Willamson JR, Chang K, Ostrow E, Allison W, Harlow J, and Kilo C. Sorbitol-induced increases in vascular albumin clearance (VAC) are prevented by pyruvate but not myo-inositol. Diabetes 38(suppl 2): 94A, 1989.
54. Williamson DH, Lund P, and Krebs HA. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J 103: 514-527, 1967.
55. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Ka-wamura T, Nyengaard JR, van den Enden M, Kilo C, and Tilton RG. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801-813, 1993.
56. Winkler BS, Arnold MJ, Brassell MA, and Sliter DR. Glucose dependence of glycolysis, hexose monophosphate shunt activity, energy status, and the polyol pathway in retinas isolated from normal (nondiabetic) rats. Invest Ophthalmol Vis Sci 38: 62-71, 1997.
57. Wolf BA, Williamson JR, Easom RA, Chang K, Sherman WR, and Turk J. Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 87: 31-38, 1991.
58. Zhao W, Devamanoharan PS, Henein M, Ali AH, and Var-ma SD. Diabetes-induced biochemical changes in rat lens: attenuation of cataractogenesis by pyruvate. Diabetes Obes Metab 2: 165-174, 2000.